Annual report pursuant to Section 13 and 15(d)

Note 18 - Stock-based Compensation

v3.24.1.u1
Note 18 - Stock-based Compensation
12 Months Ended
Jan. 31, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

(18) Stock-Based Compensation

 

Equity Incentive Plans

 

In June 2021, Skillsoft adopted the 2020 Omnibus Incentive Plan (“2020 Plan”). The 2020 Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, other equity-based awards, and cash-based incentive awards to employees, directors, and consultants of the Company. Under the 2020 Plan, 655,295 shares were initially made available for issuance. The 2020 Plan includes an annual increase on January 1 each year beginning on January 1, 2022, in an amount equal to 5.0% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year. The Compensation Committee may act prior to January 1 of a given year to provide that there will be no January 1 increase for such year or that the increase for such year will be a lesser number of shares of common stock than provided for in the 2020 Plan. As of January 31, 2024, a total of 575,619 shares of common stock were available for issuance under the 2020 Plan.

 

Stock Options

 

Under the 2020 Plan all employees are eligible to receive incentive share options and all employees, directors and consultants are eligible to receive non-statutory share options. The options generally vest over four years and have a term of ten years. Vested options under the plan generally expire not later than 90 days following termination of employment or service or twelve months following an optionee’s death or disability. The fair value of stock options is determined on the grant date and amortized over the vesting period on a straight-line basis.

 

The following summarizes the stock option activity for the fiscal year ended January 31, 2024:

 

                   

Weighted -

         
           

Weighted -

   

Average

         
           

Average

   

Remaining

   

Aggregate

 
           

Exercise

   

Contractual

   

Intrinsic Value

 
   

Shares

   

Price

   

Term (Years)

   

(in thousands)

 

Outstanding, January 31, 2023

    116,099     $ 214.74       8.4     $  

Granted

                       

Exercised

                       

Forfeited

    (11,330 )     215.00              

Expired

    (15,919 )     213.13              

Outstanding, January 31, 2024

    88,850       215.00       7.4        
                                 

Vested and exercisable, January 31, 2024

    55,533       215.00       7.4        

 

The total unrecognized equity-based compensation costs related to the stock options was $2.0 million based on the $67.23 weighted average grant date fair value of the options, which is expected to be recognized over a weighted-average period of 1.4 years.

 

Time-Based Restricted Stock Units

 

Restricted stock units (“RSUs”) represent a right to receive one share of the Company’s common stock that is both non-transferable and forfeitable unless and until certain conditions are satisfied. Other than RSUs granted to our non-employee directors, which vest upon the earlier of the anniversary of the grant date and the Company’s next annual meeting of stockholders, RSUs generally vest ratably over a three or four-year period, subject to continued employment through each anniversary. The fair value of RSUs is determined on the grant date and is amortized over the vesting period on a straight-line basis.

 

The following summarizes the time-based RSU activity for the fiscal year ended January 31, 2024:

 

           

Weighted -

   

Aggregate

 
           

Average Grant

   

Intrinsic Value

 
   

Shares

   

Date Fair Value

   

(in thousands)

 

Unvested balance, January 31, 2023

    608,306     $ 120.20     $ 23,359  

Granted(1)

    461,151       31.76        

Vested

    (172,747 )     132.85        

Forfeited

    (160,712 )     108.72        

Unvested balance, January 31, 2024

    735,998       64.77       10,319  

 

(1) In May 2023, 14,550 shares of time-based RSUs were granted to replace 19,400 shares of market-based RSUs. This modification resulted in stock-based compensation expense increasing by less than $0.1 million per quarter over a two-year period.

 

The total unrecognized stock-based compensation costs related to time-based RSUs was $35.6 million, which is expected to be recognized over a weighted-average period of 2.6 years.

 

Market-Based Restricted Stock Units

 

Market-based restricted stock units (“MBRSUs”) vest over a three-year or four-year performance period, subject to continued employment through each anniversary and achievement of market conditions, specifically the Company's stock price and an objective relative total shareholder return. The fair value of MBRSUs that include vesting based on market conditions are estimated using the Monte Carlo valuation method. Compensation cost for these awards is recognized based on the grant date fair value which is recognized over the vesting period using the accelerated attribution method.

 

The following summarizes the MBRSUs activity for the fiscal year ended January 31, 2024:

 

           

Weighted -

   

Aggregate

 
           

Average Grant

   

Intrinsic Value

 
   

Shares

   

Date Fair Value

   

(in thousands)

 

Unvested balance, January 31, 2023

    112,923     $ 135.00     $ 4,336  

Granted

    120,069       45.11        

Vested

                 

Forfeited and cancelled (1)

    (50,250 )     149.90        

Unvested balance, January 31, 2024

    182,742       72.60       2,562  

 

(1) In May 2023, 19,400 shares of market-based RSUs were canceled and replaced with 14,550 shares of time-based RSUs. This modification resulted in stock-based compensation expense increasing by less than $0.1 million per quarter over a two-year period.

 

The total unrecognized stock-based compensation costs related to MBRSUs was $4.2 million, which is expected to be recognized over a weighted-average period of 1.2 years.

 

Performance-based Restricted Stock Units

 

The Company issued 2,494 performance-based restricted stock units that have a grant-date fair value of $0.5 million during the period from June 12, 2021 through January 31, 2022 (Successor). The awards vest upon the achievement of specified corporate goals. Of the 2,494 performance-based restricted stock units, 625 shares were vested and 625 shares were canceled on January 31, 2022. The remaining 1,244 shares were vested when the specified corporate goals were achieved in June 2022. In the fiscal year ended January 31, 2023 (Successor), $0.3 million in stock-based compensation expense was recognized for these remaining shares.

 

Stock-Based Compensation Expense

 

The following summarizes the classification of stock-based compensation expense in the consolidated statements of operations (in thousands):

 

    Fiscal 2024     Fiscal 2023     Fiscal 2022  
    Successor     Successor     Successor     Predecessor  
    From     From     From     From  
   

February 1, 2023 to

   

February 1, 2022 to

   

June 12, 2021 to

   

February 1, 2021

 
   

January 31, 2024

   

January 31, 2023

   

January 31, 2022

   

to June 11, 2021

 

Cost of revenues

  $ 762     $ 232     $     $  

Content and software development

    6,294       8,850       895        

Selling and marketing

    3,794       7,336       2,043        

General and administrative

    20,217       20,204       11,726        

Total

  $ 31,067     $ 36,622     $ 14,664     $  

 

The stock-based compensation for the fiscal year ended January 31, 2023 (Successor) includes $1.6 million of fair value adjustment for the cash consideration in excess of the fair value of the legacy Codecademy options, which is classified as a post-combination expense.

 

Stock-based compensation expense for the period from June 12, 2021 through January 31, 2022 (Successor) includes $2.8 million attributable to 50,000 warrants issued to the chief executive officer that vested upon completion of the merger and his commencement of employment with the Company.